Your Sorted CME/CE Activities

Quarterly Brief (October-December 2021): A Current Expert Analysis on Important HIV Clinical Decisions
AMA/ANCC/ACPE Activities
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from October through December of 2021 will discuss the most clinically relevant information including COVID-19 in PLWH, guideline updates, HIV management strategies and investigational agents.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.
 









Faculty Chair
Paul Sax, MD Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Faculty
Laura Waters, MBBS, FRCP, MD Laura Waters, MBBS, FRCP, MD
Consultant Physician Sexual Health & HIV
Mortimer Market Centre
Central & North West London NHS Trust
 

20
Supported by an independent educational grant from ViiV Healthcare

Launch Date: January 7, 2022
Release Date: January 7, 2022
Expiration Date: December 31, 2022

December 31, 2022
Mini Module
7293
QuarterlyBrief_WebBanner_1158.gif
HIV